Drug company gifts to MDs
According to HHS Inspector General draft report, "pharmaceutical companies were more likely to offer gifts and payments to physicians who were frequent prescribers than to those who were infrequent prescribers." The IG surveyed 1,000 MDs from the fall of 1990 to the fall of 1991. The IG draft states that 27% of the MDs reported receipt of "inappropriate" gifts or payments at least once during the year examined and that such gifts were offered at least once to "36% of physicians who wrote at least 50 Rxs a week".
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth